Vanguard Capital Management
INDP icon

Vanguard Capital Management’s Indaptus Therapeutics INDP Stock Holding History

Vanguard Capital Management’s Portfolio INDP Stock Details INDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$101K Buy
+33,652
New +$84.7K ﹤0.01% 3879

Other funds holding INDP

HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return

Vanguard Capital Management's INDP Position: Q2 2026 in Review

Vanguard Capital Management opened a new position in Indaptus Therapeutics (INDP) in Q2 2026: 33,652 shares worth $101K. The stake represents ﹤0.01% of the portfolio and ranks #3879 among its holdings.

9 funds tracked by Wall St. Rank hold INDP as of Q2 2026.

  • Vanguard Capital Management held 33,652 shares of Indaptus Therapeutics worth $101K as of Q2 2026.
  • Indaptus Therapeutics was a new Vanguard Capital Management position in Q2 2026.
  • Indaptus Therapeutics made up ﹤0.01% of Vanguard Capital Management's portfolio in Q2 2026, its #3879 holding.
  • 9 funds tracked by Wall St. Rank held Indaptus Therapeutics as of Q2 2026.

Based on Vanguard Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.